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Abstract
The 60kDa heat shock protein family, Hsp60, constitutes an abundant and highly conserved class of molecules that are
highly expressed in chronic-inflammatory and autoimmune processes. Experimental autoimmune uveitis [EAU] is a T cell
mediated intraocular inflammatory disease that resembles human uveitis. Mycobacterial and homologous Hsp60 peptides
induces uveitis in rats, however their participation in aggravating the disease is poorly known. We here evaluate the effects
of the Mycobacterium leprae Hsp65 in the development/progression of EAU and the autoimmune response against the eye
through the induction of the endogenous disequilibrium by enhancing the entropy of the immunobiological system with
the addition of homologous Hsp. B10.RIII mice were immunized subcutaneously with interphotoreceptor retinoid-binding
protein [IRBP], followed by intraperitoneally inoculation of M. leprae recombinant Hsp65 [rHsp65]. We evaluated the
proliferative response, cytokine production and the percentage of CD4
+IL-17
+, CD4
+IFN-c
+ and CD4
+Foxp3
+ cells ex vivo,b y
flow cytometry. Disease severity was determined by eye histological examination and serum levels of anti-IRBP and anti-
Hsp60/65 measured by ELISA. EAU scores increased in the Hsp65 group and were associated with an expansion of CD4
+IFN-
c
+ and CD4
+IL-17
+ T cells, corroborating with higher levels of IFN-c. Our data indicate that rHsp65 is one of the managers
with a significant impact over the immune response during autoimmunity, skewing it to a pathogenic state, promoting
both Th1 and Th17 commitment. It seems comprehensible that the specificity and primary function of Hsp60 molecules can
be considered as a potential pathogenic factor acting as a whistleblower announcing chronic-inflammatory diseases
progression.
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Introduction
Uveitis is an inflammation of the uvea, a layer of the eye located
betweenthescleraandtheretina.Uveaincludestheiris,ciliarybody,
and choroid [1]. The animal model for human uveitis has
experimental autoimmune uveitis [EAU] that also resembles that
seen in diseases such as sympathetic ophthalmia, birdshot retino-
choroidopathy, Vogt-Koyanagi-Harada’s disease, and Behcet’s
disease [BD] [2]. EAU is an organ-specific T-cell-mediated disease
that can be induced in susceptible animals such as non-human
primates and rodents. Induction is done with immunization using
retinal antigens like interphotoreceptor retinoid-binding protein
[IRBP] or with S-antigen [arrestin]. It can also be done by adoptive
transfer of IRBP or arrestin-specific T-cells [2,3,4]. The disease is
characterized by vasculitis and granuloma formation in the neural
retina, destruction of photoreceptor cells, and blindness [2,4].
The 60kDa heat shock protein family, HSP60, constitutes an
abundant and highly conserved class of molecules. They prevent
misfolding and promote the refolding and proper assembly of
unfolded polypeptides generated under physiologic and stress
conditions. The Mycobacterium leprae Hsp65 [M. leprae Hsp65] is part
of the HSP60 family denominated chaperonins. It is considered
as one of the major immuno-reactive proteins in mycobacteria
[5]. Mycobacterial Hsp65 shares approximately 50% amino acid
identity with its mammalian homologue. The Hsp60 family
comprises molecules that are immunodominant in several
infectious processes [6], and which participate in pro-inflamma-
tory events associated to pathologies such as arthritis, atheroscle-
rosis, type I diabetes, and autoimmune demyelination [7,8,9]. As
for its association with eye disease more specifically, higher anti-
Hsp65 antibody titers were correlated to the retinopathy seen in
type I diabetes patients [10].
Mycobacterial and homologous Hsp60 peptides can induce
experimental uveitis in rats [11,12] and Hsp60 and anti-Hsp60
may be involved in the pathogenesis of the ocular manifestations of
Behcet’s disease and acute anterior uveitis [13,14]. However, their
participation in aggravating the disease is poorly known.
Although the etiology of autoimmune diseases still remains
unclear, it is believed that molecular mimicry is a contributing
factor [15]. The presence of antibodies and T cells that are
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suggests that these proteins play an important role as cellular
targets in autoimmunity due to an existing similarity between the
bacterial antigen and the autologous protein [16]. On the other
hand, high anti-Hsp60/65 antibody titers were not found to be
restricted to disease conditions and could also be detected in
supposedly healthy individuals as they aged [17,18]. Indeed,
autoantibodies can be indicators of susceptibility to the future
development of various autoimmune diseases [19,20,21,22].
We previously showed that passive administration of wild typeM.
leprae Hsp65 interfered with endogenous equilibrium by enhancing
the entropy of the immunobiological system, as expressed by the
early death of the systemic lupus erythematosus [NZBxNZW]F1
experimental mice [23]. We here applied a similar approach of
inducing disequilibrium of physiological and immune states by
adding homologous Hsp to evaluate the effects of the M. leprae
Hsp65 in the development/progression of EAU by evaluating the
autoimmune response against the eye. For that we analyzed the
proliferative response, cytokine and antibody production in the
B10.RIII experimental mice submitted to immunization and
administration of Hsp65. The findings were compared to the
histopathological analysis of the eye.
Results
Administration of M. leprae rHsp65 Increased EAU Scores
To evaluate the influence of rHsp65 in the progression of EAU,
B10.RIII mice were induced to develop uveitis by immunization
with IRBP followed by inoculation with rHsp65, which occurred
in the same day. Control mice showed moderate to severe signs of
EAU according to histopathologic examination done on day 21.
These signs were retinal disorganization, presence of inflamma-
tory cells in the vitreous, vasculitis and granuloma formation
[Figures 1A and 1B, control group]. Conversely, rHsp65-inoculated
animals presented a more pronounced inflammatory response,
with total disorganization of the retinal layers associated to
detachment of the retina. Intense retinal folds, inflammatory
infiltrating cells in the vitreous, vasculitis and granuloma formation
were also observed [Figures 1A and 1B, rHsp65 group]. B10.RIII
mice immunized with IRBP emulsified in incomplete Freund
adjuvant plus PTX or immunized in CFA without PTX, even
receiving rHsp65, do not express EAU [data not shown]. These
indicate that Hsp have any commitment in the initiation process of
this organ-specific autoimmune disease.
Analysis of Cytokine Levels
Draining lymph node cells from either control or rHsp65-
inoculated mice were harvested on day 21 after immunization and
assayed for cytokine secretion under IRBP and rHsp65 stimulating
conditions. We observed an increased IFN-c secretion by IRBP re-
stimulated cells, which was associated with a higher expansion of
CD4
+IFN-c
+ T cells [Figures 2A and 3A, p,0.05] in the rHsp65
group. These findings corroborate with our clinical findings, in
which an increase in the EAU score was observed. On the other
hand, no changes were observed in IFN-c after re-stimulation with
rHsp65 [Figure 2B].
Surprisingly, rHsp65 administration resulted inan increased IL-10
production after stimulation with IRBP and with rHsp65 [Figures 2C
and 2D, p,0.05]. No alterations in IL-6 production levels were
observed after IRBP and rHsp65 stimulation [Figures 2E and 2F].
rHsp65 Expanded IL-17 and IFN-c CD4
+T Cell Population
Because the Th17 cells recently described are believed to play a
relevant role in the pathogenesis of autoimmunity [24,25,26] and
the expression of Th1 is a characteristic phenotype of EAU, we
evaluated the percentage of both Th1 and Th17 cells from lymph
nodes of EAU mice inoculated with rHsp65 and compared to
controls. Intracellular staining for IFN-c and IL-17 revealed that
rHsp65 injection induced expansion of both CD4
+ T cell
populations [Figure 3]. Concerning T cell subsets, it is possible
that the higher disease scores observed in the rHsp65 group would
lead to an impaired percentage of T regulatory cells in the
periphery. However, this was not the case, as no differences in the
percentages of CD4
+Foxp3
+ T cells were observed [Figure 4].
Anti-IRBP IgG2a Levels Decreased after rHsp65
Administration
We examined the effects of rHsp65 inoculation on IRBP and
Hsp60/65 specificIgG antibodyproduction. As shown inFigure 5A,
anti-IRBP IgG2a levels decreased in the sera of the rHsp65 mice
group when compared to control [p,0.05]. No significant dif-
ferences in the levels of anti-IRBP IgG1 antibodies were observed.
Production of anti-mouse Hsp60 and anti-Hsp65 antibody
showed no difference between test and control in the mice sera
[Figure 5B]. However, production of anti-Hsp60 antibody [both in
the test group and in controls] presented titers that were
approximately 5.6-fold higher than those of anti-Hsp65 antibodies.
Discussion
Hsp60 are highly conserved molecules inducible by all forms of
cellular stress. In spite of the best known function they have as
Figure 1. Administration of M. leprae rHsp65 increased EAU scores.
[A]: B10.RIII mice were immunized with 161–180 IRBP peptide followed by
i n j e c t i o nw i t hr H s p 6 5[ i . p . ] .E y e sw e r ecollected for histopathology 21 days
later. EAU scores were assigned on a 0 to 4 scale. [B]: Histopathological
findings: a normal retinal architecture corresponding to non immunized
naı ¨ve mice [normal]; IRBP immunized mice [average score 3; control]; mice
immunized with IRBP followed by rHsp65 inoculation [average score 4;
rHsp65]. Representative photographs [hematoxilin-eosin staining] of three
independent experiments with n=6–8 mice/group. Magnification: 200x.
doi:10.1371/journal.pone.0007912.g001
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immune response, being target by Hsp-specific T cells and
antibodies in healthy subjects and also in chronic-inflammatory
processes including autoimmune diseases [6,27,28,29]. Hsp have
shown a dual role in immune-mediated disorders, being involved
in the induction and propagation of autoimmune diseases as well
as in suppressing them [30]. The precise mechanisms underlying
these divergent Hsp60-mediated responses are not defined. It has
been suggested that the increased expression of endogenous Hsp
molecules in different stress conditions can propagate the ongoing
inflammation and also constitutes an attractive target for T cells
and antibodies that are induced by extracellular [self or foreign]
Hsp. In addition, inflammation can alter the antigen processing for
Hsp and reveal new epitopes which can prime an immune
response and lead to pathological status [31]. Furthermore, these
molecules activate innate immunity through macrophages and
dendritic cells, which in turn trigger the development of adaptive
Figure 2. rHsp65 inoculation increased IFN-c and IL-10 levels.
Draining lymph nodes cells from either rHsp65 inoculated or control
mice were harvested at day 21 and stimulated in vitro [10
6 cells/ml] with
30 mg/ml IRBP [A, C, E] and 20 mg/ml M. leprae rHsp65 [B, D, F]. After
48 hours, IFN-c [A, B], IL-10 [C, D] and IL-6 [E, F] levels were determined
by ELISA. Data represent three independent experiments with n=5
mice/group [*p,0.05 versus control group; t-test analysis].
doi:10.1371/journal.pone.0007912.g002
Figure 3. Expansion of CD4
+IFN-c
+ and CD4
+IL-17
+ T cells after
rHsp65 inoculation. Cells from draining lymph nodes collected at day
21 after immunization were labeled with anti-CD4 mAb, fixed and
permeabilized, stained intracellularly and analyzed by flow-cytometry
evaluating the CD4, IFN-c and IL-17 expression. Results are expressed in
mean 6 SD. Data represent three independent experiments with n=5
mice/group [*p,0.05; **p,0.01 versus control group; t-test analysis].
doi:10.1371/journal.pone.0007912.g003
Figure 4. rHsp65 showed no effect on CD4+Foxp3+ T cells. Cells
from draining lymph nodes were harvested at day 21 after immuniza-
tion, stained and analyzed by flow-cytometry evaluating the CD4 and
Foxp3 expressions. Results are expressed in mean 6 SD. Data represent
three independent experiments with n=5 mice/group.
doi:10.1371/journal.pone.0007912.g004
Figure 5. rHsp65 modulated anti-IRBP IgG2a levels. Serum levels
of anti-IRBP IgG1 and IgG2a isotypes [A] and IgG anti-mouse Hsp60 and
anti-rHsp65 [B] antibody production in IRBP-immunized mice either or
not inoculated with rHsp65. Antibody levels were determined by ELISA
at day 21 after immunization. Results are expressed in titers 6 SD in
each experimental group. Data represent three independent experi-
ments with n=6–8 mice/group [*p,0.05 versus control group; t-test
analysis].
doi:10.1371/journal.pone.0007912.g005
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Besides that, anti-Hsp65 antibodies can also be a potent
pathological trigger [7,32]. The immune response to Hsp can be
mined for information on the state of the immune system [33,34];
in altered conditions, Hsp and their antibodies can act as
biomarkers during postnatal life [20,35].
In this study we showed that a single administration of M. leprae
rHsp65 in the highly susceptible B10.RIII immunized mouse was
capable to increase the scores of uveitis when compared to controls
[p,0.05]. Also, rHsp65-inoculated animals presented a more
pronounced inflammatory response, with total disorganization of
the retinal layers associated to its detachment. Intense retinal folds,
inflammatory infiltrating cells in the vitreous, vasculitis and
granuloma formation were also observed.
Most reports that attempted to correlate Hsp60 with uveitis
were limited to studies done with systemic Behcet’s disease
[11,36,37,38]; increased T and B cell activity against Hsp60 and
Hsp65 has been documented in these patients [11,39,40,41]. The
inoculation of bacterial Hsp65 peptides either subcutaneously or
orally, or their human analogues, induced uveitis in Lewis rats by
self-reactive T cells specific to these peptides. Although the Hsp60
family members share a common basic antigenicity, they differ in
the reactivity to the anti-Hsp60 antibodies present in the sera of
BD patients [42]. Cancino-Diaz and collaborators hypothesized
that the high levels of anti-bacterial Hsp60 antibodies found in
patients with uveitis was produced during episodes of bacterial
infection that may have triggered an autoimmune reaction
through a mechanism of molecular mimicry between the human
and microbial Hsp. This suggests also that an immune cross-
reaction between retinal and Hsp molecules and a related
autoimmune response may be involved in the development of
BD [41].
Many studies showed Hsp60 as a ligand for TLR-2 and TLR-4,
suggesting a role for Hsp60 as an immunological and endogenous
sign of danger that leads to rapid inflammatory cytokine release and
enhancementofadaptiveTh1-type responses[43,44,45,46].Genetic
susceptibility to EAU is associated to a dominant Th1-type response
to the uveitogenic retinal antigen; the effector T cells possess a Th1-
like phenotype that is expressed as high IFN-c and low IL-4
cytokines production [47,48]. In our study, the levels of IFN-c
secretion and the percentage of CD4
+IFN-c
+ and CD4
+IL-17
+ cells
were significantly higher in the rHsp65 group than in control mice.
IL-17-producing CD4
+ T cells or Th17 constitute a newly identified
inflammatory cell population, which is critically involved in EAU
[24,25,49] suggesting that rHsp65 aggravates EAU pathology by
expanding antigen-specific Th1 and Th17 cells. Knowing that IL-6
isassociatedwiththeproductionoftheTh17effectorphenotype[50]
and that the cytokine is responsible, at least partially, for an ocular
inflammation in which differentiation of Th17 is IL-6-dependent
[26], we expected to see an increased secretion of IL-6 in rHsp65-
inoculated mice. Expansion of Th17 did not reflect in a higher
production ofIL-6 inthe rHsp65 group,whencompared tocontrols.
The analysis of the kinetics of cytokine secretion and other time-
points may have showed otherwise and explain the lack of
differential IL-6 production, in the rHsp65 group and emerge an
increase of IL-10 production by IRBP and Hsp65-specific cells.
Although IL-10 has been implicated in the progression control of
immune-mediated diseases and in the maintenance of tolerance
[51,52], in our study it did not correlate with suppression, since the
EAU score was higher in animals that received Hsp65.
Concerning T cell subsets, it is possible that the higher disease
scores observed in the rHsp65 group would lead to an impaired
percentage of T regulatory cells in the periphery. However, this
was not the case, as no differences in the percentages of
CD4
+Foxp3
+ T cells were observed. The elevated IL-10
production in this context may works as an attempt to control
the balance Th2/Th1 during the intense inflammatory response
caused by the administration of rHsp65, other than being an
attempt to regulate the response to self antigens. The higher IL-10
cytokine production and the decrease in IgG2a anti-IRBP levels in
rHsp65-inoculated mice reinforce the notion of reacquired
homeostasis states.
No significant differences in the production of anti-mouse
Hsp60 and anti-Hsp65 antibody levels in both rHsp65 and control
groups were observed [Figure 5B]. However, the anti-Hsp65
antibody production was higher in B10.RIII immunized than
naı ¨ve mice, which showed basal production [data not shown]. The
high anti-Hsp60/65 antibody titers were not found to be restricted
to disease conditions. That they were detected in supposedly
healthy individuals [17,18] may be due to the fact that the
pathophysiologic status of the individuals were not deeply
investigated. However, we cannot rule out that anti-Hsp65
antibodies are involved in vascular damage and consequently
aggravate ocular disease in Hsp65-inoculated mice, since EAU can
present vasculitis and granuloma formation in the neural retina
[2,4]. Indeed, it was reported that the anti-Hsp60 autoantibodies
mediates endothelial cell cytotoxicity [53]. The possible correla-
tion between anti-Hsp65 antibodies and vascular lesions and the
physiopathological mechanisms involving pro-inflammatory cyto-
kines in the serum of inoculated and control mice may clarify the
role of these soluble molecules in the severity of uveitis.
Hsp have been implicated in the induction and propagation of
autoimmunity in several diseases. Our findings demonstrate that
this may also be true in uveitis and it opens the possibility that the
blockage of endogenous produced Hsp, whose expression should
be enhanced during autoimmunity, may present an interesting
target for immunotherapy of this syndrome of the eye.
Furthermore, in infectious diseases of the eye, such as toxoplas-
mosis, recurrence of lesions often go unexplained and because Hsp
are highly conserved in nature it is entirely possible that the
pathogen’s Hsp may contribute to disease flare up.
Through an original approach based in the Prigogine’s principle
[54,55], the pathophysiological role of the rHsp65 of M. leprae was
also evaluated in the in vivo spontaneous Systemic Lupus
Erythematosus [SLE] model. It is assumed that the immune
system keeps the order state at the cost of irreversibility and that in
faster reiterated rounds of stimulation the system is not able to
come back to its original state [23]. Both in the organ-specific
EAU and in the systemic SLE, these findings strongly support that
the over expression of the Hsp family and the altered
microenvironmental state in pathologic conditions can modify
the antigen processing of Hsps molecules, providing it a toxin
function.
The adaptive management of biological systems according to
environmental changes is mandatory for the organism survival and
the Hsp molecules may intervene in the quantitative and
qualitatively immune phenotypes submitted to independent
polygenic controls, such as inflammatory and antibody respon-
siveness or immunological tolerance [56,57,58,59]. With the
aggravation of an autoimmune process, the organism is incapable
to regenerate the affected tissues, and unable to return to the
original immune state. Thus, aggravation of an autoimmune
process can be defined as irreversible phenomena [23]. Despite the
strategy of balancing the immune response to solve the acute
ocular inflammation, the immune system tries to regulate the Th1
proinflammatory response through the production of immunosu-
pressor cytokines. The B10.RIII immunized mice followed by
rHsp65 administration were unable to revert to its original visual
Hsp65 in Autoimmune Uveitis
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effect of the immune system.
Our data suggest that Hsp65 has pathological significance
during the ocular autoimmune disease by increasing the immune
response associated with an expansion of CD4
+IFN-c
+ and
CD4
+IL-17
+ T cells, probably by skewing it to a pathogenic state,
promoting both Th1 and Th17 commitment.
These findings can be used for a better understanding of the
relationship between self molecules, such as Hsp, and the immune
response under physiological and pathological conditions. The
specificity and primary function of Hsp60 can be considered as a
potential pathogenic factor that also may act as a whistleblower
announcing chronic-inflammatory diseases progression. It may be
consider the immune system as a broken mirror in which identical
or similar images, or their own reflections, distinctly recognized or
blurred. In this sense, depending on the pathophysiological
conditions, unpredictable immune responsiveness will be evoked
by cumulative and temporal effects.
Materials and Methods
Antigens and Reagents
Peptide SGIPYIISYLHPGNTILHVD representing residues
161–180 of IRBP was synthesized using the Fmoc procedure
[60] in a Shimadzu PSSM8 peptide synthesizer [Shimadzu,
Tokyo, Japan]. The Fmoc-amino acids were purchased from
Novabiochem [Nottingham, UK]. Bordetella pertussis toxin and
Complete Freund Adjuvant [CFA] were purchased from Sigma-
Aldrich [St. Louis, MO, USA]. Purified mouse Hsp60 [ESP-741]
was obtained from Stressgen Bioreagents [San Diego, CA, EUA].
Expression and Purification of the Recombinant
Mycobaterium leprae Hsp65 in Escherichia coli
Clone pIL161 containing the coding sequence of the M. leprae
Hsp65 was kindly given by Prof. Ce ´lio L. Silva from University of
Sao Paulo, Ribeira ˜o Preto, Brazil. The clone was amplified in E.
coli DH5a cells. Expression of the recombinant wild-type Hsp65
protein [rHsp65] was performed as described in [61]. The rHsp65
present in the bacterial pellet was solubilized with 6 M urea and
submitted to preparative SDS-PAGE gel. Elution of the Hsp65
band from the polyacrylamide gel slice was performed to obtain
the purified protein [23]. Concentration of the recombinant
Hsp65 protein was determined using the Bradford assay [62].
Animals
Six to eight weeks old B10.RIII mice were obtained from the
animal facilities at the University of Sao Paulo, Brazil. All animals
were housed under specific pathogen-free conditions and handled
under ethical conditions. The Animal Care Committee of the
Institute of Biomedical Sciences at the University of Sao Paulo
approved all the procedures used in this study.
Induction of EAU and rHsp65 Treatment
Mice were immunized subcutaneously [s.c.] at the base of the
tail with 30 mg of 161–180 IRBP peptide emulsified in 0.2 ml CFA
[v/v] and injected intraperitoneally [i.p.] with 0.5 mgo fBordetella
pertussis toxin [PTX] in 0.1 ml, as additional adjuvant. Following
immunization, a group of 6 to 8 animals was inoculated with
2.5 mgo fM. leprae rHsp65 in 0.2 ml of phosphate buffer saline
pH 7.4 [PBS] by i.p. route. At day 21 after immunization, rHsp65
inoculated and control mice were sacrificed. The histopathology of
the eye, cellular phenotype, cytokines and anti–IRBP and anti-
Hsp60/Hsp65 antibody production were then analyzed.
Histopathology EAU
Eyes were collected and prepared for histopathological evalua-
tion at day 21 after immunization. The eyes were immersed for 1 h
in phosphate-buffered glutaraldehyde 4%, transferred into phos-
phate-buffered formaldehyde 10% for 24 h, and to ethanol 70%
until processing. Fixed and dehydrated tissues were embedded in
paraffin wax; 4–6 mm sections were cut through the papillary-optic
nerve plane. Sections were stained by hematoxylin and eosin.
Presence of disease was evaluated in a double-blinded fashion
by examining six sections cut at different levels in each eye.
Severity of EAU was scored on a scale of 0 [no disease] to 4
[maximum disease] in half-point increments, according to a semi
quantitative system described previously [2] and which considers
the lesion type, size, and number. The minimal EAU score is
characterized by inflammatory cell infiltration of the ciliary body,
choroids, or retina [EAU score 0.5]. Progressively higher scores
were assigned according to the amount, in the tissues, of discrete
lesions such as vasculitis, granuloma formation, retinal folding
and/or detachment and photoreceptor damage.
Determination of Cytokine Production
Draining lymph node cells harvested at day 21 after
immunization were cultured in 24-well plates [10
6 cells/ well]
and stimulated with 30 mg/ml IRBP or 20 mg/ml M. leprae
rHsp65. Supernatants were collected for cytokine analysis after
48 h and stored at 280uC until assayed. The IFN-c, IL-10 and IL-
6 cytokines were detected with the ELISA kit from eBiosciences
[San Diego, CA, USA] or BD Pharmingen [La Jolla, CA, USA]
according to the manufacturer’s instructions.
Flow Cytometry
L y m p hn o d ec e l l sw e r ei n c u b a t e df o r2 0m i no ni c ew i t hF cb l o c k
[hamster anti-mouse CD16/CD32, clone 24G2; BD Pharmingen,
San Diego, CA, USA] and labeled with anti-CD4 PE-Cy5 [BD
Pharmingen, San Diego, CA, USA], anti-CD25 PE [BD Pharmin-
gen, San Diego, CA, USA] or matched isotype controls for an
additional 30 minutes. All antibodies were obtained from BD
Pharmingen[SanDiego,CA,USA].ForintracellularFoxp3staining,
cells were fixed and permeabilized according to the manufacturer’s
procedure for the staining set [eBioscience, San Diego, CA, USA]
and labeled with PE-conjugated anti-mouse Foxp3 antibody. Cells
were washed and then analyzed by flow-cytometry.
For intracellular detection of IFN-c and IL-17, cells were
collected and stimulated for 5 h with 50 ng/ml phorbol myristate
acetate [PMA] [Sigma-Aldrich, St. Louis, MO, USA] and
750 ng/ml ionomycin [Calbiochem, La Jolla, CA, USA] in the
presence of Golgistop at the recommended concentrations [BD
Pharmingen, San Diego, CA, USA]. Another group of cells was
not stimulated and used as a control. Both groups of cells
[stimulated and control] were stained with fluorescein conjugated
anti-CD4+, fixed and permeabilized with Cytofix/Cytoperm
solution [BD Pharmingen, San Diego, CA, USA] and then
labeled with FITC-conjugated anti-IFN-c and PE-conjugated
anti-IL-17 [BD Pharmingen, San Diego, CA, USA]. Samples were
acquired on a FACSCalibur [BD Pharmingen, San Diego, CA,
USA] and data were analyzed with CellQuest-Pro software [BD
Pharmingen, San Diego, CA, USA].
Titration of Anti-IRBP, Anti-mouse Hsp60 and Anti-Hsp65
Antibodies
Levels of anti–IRBP, anti-Hsp60 and anti-Hsp65 IgG or IgG1
and IgG2a isotypes were determined in control and in rHsp65
inoculated mice sera, by ELISA. Briefly, 96–well microtiter plates
Hsp65 in Autoimmune Uveitis
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of one of the following: IRBP, Mycobacterium leprae rHsp65, or
mouse Hsp60, diluted in 0.1 M NaHCO3
- pH 9.6, overnight at
4uC. Plates were washed three times with PBS containing 0.05%
Tween 20 [PBS–T]. Further steps were performed as described in
[23]. Serum was serially diluted starting at 1:16. Peroxidase–
labeled anti-mouse IgG [1:2500], IgG1 [1:1000] or IgG2a
[1:1000] were obtained from BD Pharmingen [San Diego, CA,
USA]. The antibody titers were expressed as log2 of the reciprocal
serum dilution giving an absorbance value of 20% of the
saturation level.
Statistical Analysis
Results are expressed as mean values 6 standard deviation. The
statistical significance was determined by unpaired t-test and set at
p,0.05 using the GraphPad Prism 4.0 software [La Jolla, CA,
USA].
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